Copyright Reports & Markets. All rights reserved.

Global Computer-assisted Drug Design Platform Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Computer-assisted Drug Design Platform
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Computer-assisted Drug Design Platform by Type
    • 1.3.1 Overview: Global Computer-assisted Drug Design Platform Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Computer-assisted Drug Design Platform Consumption Value Market Share by Type in 2023
    • 1.3.3 Cloud-based
    • 1.3.4 On-premise
  • 1.4 Global Computer-assisted Drug Design Platform Market by Application
    • 1.4.1 Overview: Global Computer-assisted Drug Design Platform Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Drug Discovery and Development
    • 1.4.3 Computational Physiological Medicine
    • 1.4.4 Disease Modeling
    • 1.4.5 Medical Imaging
    • 1.4.6 Predictive Analysis of Drug Targets
  • 1.5 Global Computer-assisted Drug Design Platform Market Size & Forecast
  • 1.6 Global Computer-assisted Drug Design Platform Market Size and Forecast by Region
    • 1.6.1 Global Computer-assisted Drug Design Platform Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Computer-assisted Drug Design Platform Market Size by Region, (2019-2030)
    • 1.6.3 North America Computer-assisted Drug Design Platform Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Computer-assisted Drug Design Platform Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Computer-assisted Drug Design Platform Market Size and Prospect (2019-2030)
    • 1.6.6 South America Computer-assisted Drug Design Platform Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Computer-assisted Drug Design Platform Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Entelos
    • 2.1.1 Entelos Details
    • 2.1.2 Entelos Major Business
    • 2.1.3 Entelos Computer-assisted Drug Design Platform Product and Solutions
    • 2.1.4 Entelos Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Entelos Recent Developments and Future Plans
  • 2.2 Crown Bioscience
    • 2.2.1 Crown Bioscience Details
    • 2.2.2 Crown Bioscience Major Business
    • 2.2.3 Crown Bioscience Computer-assisted Drug Design Platform Product and Solutions
    • 2.2.4 Crown Bioscience Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Crown Bioscience Recent Developments and Future Plans
  • 2.3 Chemical Computing Group
    • 2.3.1 Chemical Computing Group Details
    • 2.3.2 Chemical Computing Group Major Business
    • 2.3.3 Chemical Computing Group Computer-assisted Drug Design Platform Product and Solutions
    • 2.3.4 Chemical Computing Group Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Chemical Computing Group Recent Developments and Future Plans
  • 2.4 Nimbus Therapeutics
    • 2.4.1 Nimbus Therapeutics Details
    • 2.4.2 Nimbus Therapeutics Major Business
    • 2.4.3 Nimbus Therapeutics Computer-assisted Drug Design Platform Product and Solutions
    • 2.4.4 Nimbus Therapeutics Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Nimbus Therapeutics Recent Developments and Future Plans
  • 2.5 Schrodinger
    • 2.5.1 Schrodinger Details
    • 2.5.2 Schrodinger Major Business
    • 2.5.3 Schrodinger Computer-assisted Drug Design Platform Product and Solutions
    • 2.5.4 Schrodinger Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Schrodinger Recent Developments and Future Plans
  • 2.6 Dassault Systemes
    • 2.6.1 Dassault Systemes Details
    • 2.6.2 Dassault Systemes Major Business
    • 2.6.3 Dassault Systemes Computer-assisted Drug Design Platform Product and Solutions
    • 2.6.4 Dassault Systemes Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Dassault Systemes Recent Developments and Future Plans
  • 2.7 Genedata
    • 2.7.1 Genedata Details
    • 2.7.2 Genedata Major Business
    • 2.7.3 Genedata Computer-assisted Drug Design Platform Product and Solutions
    • 2.7.4 Genedata Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Genedata Recent Developments and Future Plans
  • 2.8 Biognos
    • 2.8.1 Biognos Details
    • 2.8.2 Biognos Major Business
    • 2.8.3 Biognos Computer-assisted Drug Design Platform Product and Solutions
    • 2.8.4 Biognos Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Biognos Recent Developments and Future Plans
  • 2.9 Leadscope
    • 2.9.1 Leadscope Details
    • 2.9.2 Leadscope Major Business
    • 2.9.3 Leadscope Computer-assisted Drug Design Platform Product and Solutions
    • 2.9.4 Leadscope Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Leadscope Recent Developments and Future Plans
  • 2.10 Rhenovia Pharma Limited
    • 2.10.1 Rhenovia Pharma Limited Details
    • 2.10.2 Rhenovia Pharma Limited Major Business
    • 2.10.3 Rhenovia Pharma Limited Computer-assisted Drug Design Platform Product and Solutions
    • 2.10.4 Rhenovia Pharma Limited Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Rhenovia Pharma Limited Recent Developments and Future Plans
  • 2.11 Compugen
    • 2.11.1 Compugen Details
    • 2.11.2 Compugen Major Business
    • 2.11.3 Compugen Computer-assisted Drug Design Platform Product and Solutions
    • 2.11.4 Compugen Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Compugen Recent Developments and Future Plans
  • 2.12 Certara LP
    • 2.12.1 Certara LP Details
    • 2.12.2 Certara LP Major Business
    • 2.12.3 Certara LP Computer-assisted Drug Design Platform Product and Solutions
    • 2.12.4 Certara LP Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Certara LP Recent Developments and Future Plans
  • 2.13 Prosarix
    • 2.13.1 Prosarix Details
    • 2.13.2 Prosarix Major Business
    • 2.13.3 Prosarix Computer-assisted Drug Design Platform Product and Solutions
    • 2.13.4 Prosarix Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Prosarix Recent Developments and Future Plans
  • 2.14 Simulations Plus
    • 2.14.1 Simulations Plus Details
    • 2.14.2 Simulations Plus Major Business
    • 2.14.3 Simulations Plus Computer-assisted Drug Design Platform Product and Solutions
    • 2.14.4 Simulations Plus Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Simulations Plus Recent Developments and Future Plans
  • 2.15 Strand Life Sciences
    • 2.15.1 Strand Life Sciences Details
    • 2.15.2 Strand Life Sciences Major Business
    • 2.15.3 Strand Life Sciences Computer-assisted Drug Design Platform Product and Solutions
    • 2.15.4 Strand Life Sciences Computer-assisted Drug Design Platform Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Strand Life Sciences Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Computer-assisted Drug Design Platform Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Computer-assisted Drug Design Platform by Company Revenue
    • 3.2.2 Top 3 Computer-assisted Drug Design Platform Players Market Share in 2023
    • 3.2.3 Top 6 Computer-assisted Drug Design Platform Players Market Share in 2023
  • 3.3 Computer-assisted Drug Design Platform Market: Overall Company Footprint Analysis
    • 3.3.1 Computer-assisted Drug Design Platform Market: Region Footprint
    • 3.3.2 Computer-assisted Drug Design Platform Market: Company Product Type Footprint
    • 3.3.3 Computer-assisted Drug Design Platform Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Computer-assisted Drug Design Platform Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Computer-assisted Drug Design Platform Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Computer-assisted Drug Design Platform Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Computer-assisted Drug Design Platform Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Computer-assisted Drug Design Platform Consumption Value by Type (2019-2030)
  • 6.2 North America Computer-assisted Drug Design Platform Consumption Value by Application (2019-2030)
  • 6.3 North America Computer-assisted Drug Design Platform Market Size by Country
    • 6.3.1 North America Computer-assisted Drug Design Platform Consumption Value by Country (2019-2030)
    • 6.3.2 United States Computer-assisted Drug Design Platform Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Computer-assisted Drug Design Platform Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Computer-assisted Drug Design Platform Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Computer-assisted Drug Design Platform Consumption Value by Type (2019-2030)
  • 7.2 Europe Computer-assisted Drug Design Platform Consumption Value by Application (2019-2030)
  • 7.3 Europe Computer-assisted Drug Design Platform Market Size by Country
    • 7.3.1 Europe Computer-assisted Drug Design Platform Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Computer-assisted Drug Design Platform Market Size and Forecast (2019-2030)
    • 7.3.3 France Computer-assisted Drug Design Platform Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Computer-assisted Drug Design Platform Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Computer-assisted Drug Design Platform Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Computer-assisted Drug Design Platform Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Computer-assisted Drug Design Platform Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Computer-assisted Drug Design Platform Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Computer-assisted Drug Design Platform Market Size by Region
    • 8.3.1 Asia-Pacific Computer-assisted Drug Design Platform Consumption Value by Region (2019-2030)
    • 8.3.2 China Computer-assisted Drug Design Platform Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Computer-assisted Drug Design Platform Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Computer-assisted Drug Design Platform Market Size and Forecast (2019-2030)
    • 8.3.5 India Computer-assisted Drug Design Platform Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Computer-assisted Drug Design Platform Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Computer-assisted Drug Design Platform Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Computer-assisted Drug Design Platform Consumption Value by Type (2019-2030)
  • 9.2 South America Computer-assisted Drug Design Platform Consumption Value by Application (2019-2030)
  • 9.3 South America Computer-assisted Drug Design Platform Market Size by Country
    • 9.3.1 South America Computer-assisted Drug Design Platform Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Computer-assisted Drug Design Platform Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Computer-assisted Drug Design Platform Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Computer-assisted Drug Design Platform Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Computer-assisted Drug Design Platform Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Computer-assisted Drug Design Platform Market Size by Country
    • 10.3.1 Middle East & Africa Computer-assisted Drug Design Platform Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Computer-assisted Drug Design Platform Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Computer-assisted Drug Design Platform Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Computer-assisted Drug Design Platform Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Computer-assisted Drug Design Platform Market Drivers
  • 11.2 Computer-assisted Drug Design Platform Market Restraints
  • 11.3 Computer-assisted Drug Design Platform Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Computer-assisted Drug Design Platform Industry Chain
  • 12.2 Computer-assisted Drug Design Platform Upstream Analysis
  • 12.3 Computer-assisted Drug Design Platform Midstream Analysis
  • 12.4 Computer-assisted Drug Design Platform Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Computer-assisted Drug Design Platform market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
    The Global Info Research report includes an overview of the development of the Computer-assisted Drug Design Platform industry chain, the market status of Drug Discovery and Development (Cloud-based, On-premise), Computational Physiological Medicine (Cloud-based, On-premise), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Computer-assisted Drug Design Platform.
    Regionally, the report analyzes the Computer-assisted Drug Design Platform markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Computer-assisted Drug Design Platform market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Computer-assisted Drug Design Platform market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Computer-assisted Drug Design Platform industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Cloud-based, On-premise).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Computer-assisted Drug Design Platform market.
    Regional Analysis: The report involves examining the Computer-assisted Drug Design Platform market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Computer-assisted Drug Design Platform market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Computer-assisted Drug Design Platform:
    Company Analysis: Report covers individual Computer-assisted Drug Design Platform players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Computer-assisted Drug Design Platform This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Drug Discovery and Development, Computational Physiological Medicine).
    Technology Analysis: Report covers specific technologies relevant to Computer-assisted Drug Design Platform. It assesses the current state, advancements, and potential future developments in Computer-assisted Drug Design Platform areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Computer-assisted Drug Design Platform market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Computer-assisted Drug Design Platform market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Cloud-based
    On-premise
    Market segment by Application
    Drug Discovery and Development
    Computational Physiological Medicine
    Disease Modeling
    Medical Imaging
    Predictive Analysis of Drug Targets
    Market segment by players, this report covers
    Entelos
    Crown Bioscience
    Chemical Computing Group
    Nimbus Therapeutics
    Schrodinger
    Dassault Systemes
    Genedata
    Biognos
    Leadscope
    Rhenovia Pharma Limited
    Compugen
    Certara LP
    Prosarix
    Simulations Plus
    Strand Life Sciences
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Computer-assisted Drug Design Platform product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Computer-assisted Drug Design Platform, with revenue, gross margin and global market share of Computer-assisted Drug Design Platform from 2019 to 2024.
    Chapter 3, the Computer-assisted Drug Design Platform competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Computer-assisted Drug Design Platform market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Computer-assisted Drug Design Platform.
    Chapter 13, to describe Computer-assisted Drug Design Platform research findings and conclusion.

    Buy now